Give me acute coronary syndrome,pathophysiology,evaluation types,management

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"acute coronary syndrome" AND management

Searching the Web

2025 ACC AHA acute coronary syndromes guideline evaluation management

Reading File
Reading File
Reading File
Reading Web Page

https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/…

Acute Coronary Syndrome (ACS)

ACS is a spectrum of clinical conditions caused by sudden reduction in coronary blood flow, resulting in myocardial ischemia or infarction. It is a medical emergency.

Types of ACS

TypeECGCardiac troponinUsual mechanism
ST-elevation myocardial infarction (STEMI)Persistent ST-segment elevation or equivalent ischemic patternElevatedUsually acute, complete coronary occlusion
Non-ST-elevation MI (NSTEMI)ST depression, T-wave inversion, or sometimes normal/nonspecific ECGElevated with rise/fallUsually partial or intermittent coronary occlusion
Unstable angina (UA)May be normal or show ischemic changesNot elevatedIschemia without detectable myocyte necrosis
The ECG separates STEMI from non-ST-elevation presentations, while cardiac biomarkers distinguish NSTEMI from unstable angina. Harrison's Principles of Internal Medicine, 22e, p. 286-1.

Pathophysiology

  1. Underlying atherosclerosis
    • Lipid-rich plaques form in coronary arteries.
    • Inflammation, smoking, hypertension, diabetes, and dyslipidemia promote plaque instability.
  2. Plaque rupture or erosion
    • The fibrous cap ruptures or the endothelial surface erodes.
    • Thrombogenic plaque contents are exposed to circulating blood.
  3. Platelet activation and thrombus formation
    • Platelets adhere, activate, and aggregate.
    • Coagulation produces fibrin, enlarging the thrombus.
  4. Reduced coronary perfusion
    • Complete and persistent occlusion usually produces STEMI.
    • Partial/intermittent occlusion more often produces NSTEMI or unstable angina.
  5. Myocardial ischemia and necrosis
    • Ischemia causes chest pain and electrical instability.
    • Prolonged ischemia causes irreversible myocyte death, elevated troponin, left-ventricular dysfunction, arrhythmias, shock, and mechanical complications.
STEMI typically follows rapid thrombotic occlusion at a disrupted atherosclerotic plaque, rather than slow progression of a stable stenosis. Harrison's Principles of Internal Medicine, 22e, p. 286-1.

Evaluation of Suspected ACS

1. Immediate assessment

  • ABCs, vital signs, oxygen saturation, cardiac monitoring.
  • Focused history:
    • Chest pressure, heaviness, tightness, or pain
    • Radiation to arm, shoulder, jaw, back, or epigastrium
    • Dyspnea, diaphoresis, nausea/vomiting, syncope
    • Onset, duration, exertional/rest symptoms
    • Risk factors and prior CAD/MI/PCI/CABG
  • Examine for heart failure, shock, murmur of acute mitral regurgitation, arrhythmia, or signs of alternative diagnoses.
Atypical symptoms are common in older adults, women, and people with diabetes.

2. 12-lead ECG

  • Obtain and interpret within 10 minutes of first medical contact.
  • Repeat ECGs if the first ECG is nondiagnostic but symptoms persist.
  • Look for:
    • STEMI or STEMI-equivalent patterns
    • ST depression or dynamic T-wave inversion suggesting NSTE-ACS
    • New ischemic changes or arrhythmias

3. Cardiac biomarkers

  • Use high-sensitivity cardiac troponin, with serial testing to detect a rise and/or fall.
  • Troponin above the 99th percentile indicates myocardial injury, but the clinical setting determines whether it is type 1 MI, type 2 MI, myocarditis, pulmonary embolism, renal disease, etc.
  • In a clear STEMI, reperfusion must not be delayed while waiting for troponin results. Tintinalli's Emergency Medicine, p. 384.

4. Additional tests

  • CBC, electrolytes, renal function, glucose, coagulation profile, lipid profile, HbA1c.
  • Chest radiograph if another diagnosis or complication is suspected.
  • Echocardiography: regional wall-motion abnormalities, LV function, mechanical complications, and alternate diagnoses.
  • Coronary angiography for STEMI and high-risk NSTEMI.
  • Coronary CT angiography may help selected low-to-intermediate-risk patients after initial assessment.

5. Risk stratification

  • GRACE score: ischemic/mortality risk in NSTE-ACS.
  • TIMI score: ischemic risk.
  • Assess bleeding risk before antithrombotic therapy.
High-risk indicators include recurrent ischemia, raised troponin, dynamic ST changes, hemodynamic instability, heart failure, ventricular arrhythmia, and cardiogenic shock.

Management

Initial measures for all suspected ACS

  1. Activate emergency/cardiology and cath-lab pathways as appropriate.
  2. Continuous ECG monitoring, IV access, defibrillator readiness.
  3. Aspirin promptly, unless true allergy or active major bleeding.
  4. Add a P2Y12 inhibitor when indicated as part of dual antiplatelet therapy.
  5. Anticoagulation according to ACS type and planned invasive strategy.
  6. Nitrates for persistent ischemic pain if blood pressure is adequate.
    • Avoid with hypotension, suspected right-ventricular infarction, or recent phosphodiesterase-5 inhibitor use.
  7. Oxygen only if hypoxemic, respiratory distress, or shock. Do not give routinely to normoxemic patients.
  8. Analgesia when pain persists despite anti-ischemic therapy. Morphine is used cautiously.
  9. Start a high-intensity statin early.
  10. Consider beta-blocker if no acute heart failure, shock, severe bradycardia, AV block, or bronchospasm.

STEMI: immediate reperfusion

Primary percutaneous coronary intervention (PCI) is preferred and should be performed as rapidly as possible.
  • Give aspirin, P2Y12 inhibition, and procedural anticoagulation.
  • If timely PCI is unavailable and symptom onset is recent with no contraindication, give fibrinolysis, then transfer for angiography/PCI.
  • Rescue PCI is required if fibrinolysis fails or instability continues.
  • Treat complications: ventricular arrhythmia, acute pulmonary edema, cardiogenic shock, and mechanical complications.

NSTEMI and unstable angina

Do not use routine fibrinolysis.
Management is based on ischemic and bleeding risk:
  • Aspirin plus a P2Y12 inhibitor.
  • Anticoagulation.
  • Anti-ischemic therapy: nitrates, beta-blocker when appropriate, statin.
  • Immediate invasive strategy for refractory ischemia, hemodynamic/electrical instability, shock, or acute heart failure.
  • Early invasive coronary angiography for high-risk patients, such as those with positive troponin, dynamic ST-T changes, high GRACE score, or recurrent symptoms.
  • Lower-risk patients may have selective invasive evaluation guided by clinical course and noninvasive testing.

Secondary prevention after ACS

  • Dual antiplatelet therapy is generally continued for at least 12 months if bleeding risk is not high.
  • High-intensity statin and LDL-lowering escalation if needed.
  • ACE inhibitor/ARB for LV dysfunction, hypertension, diabetes, or chronic kidney disease.
  • Beta-blocker especially with reduced LV function or recurrent angina.
  • Smoking cessation, cardiac rehabilitation, exercise and diet counseling, diabetes/BP control, and medication adherence.
The current ACC/AHA guideline supports aspirin plus an oral P2Y12 inhibitor as the default DAPT strategy for at least 12 months in ACS patients without high bleeding risk, and recommends high-intensity statin therapy for all ACS patients. It also favors radial access and complete revascularization when appropriate. ACC 2025 ACS guideline summary
Clinical safety point: New chest pressure, breathlessness, fainting, diaphoresis, or pain radiating to the arm/jaw should be treated as an emergency. Call local emergency services rather than driving to hospital.

Find the latest ACS guidelines and key treatment timelines

Reading File
Reading File
Finding Sources
Finding Sources
Searching the Web

2025 ACC AHA ACEP NAEMSP SCAI guideline acute coronary syndromes full guideline key recommendations time to ECG primary PCI fibrinolysis

Searching the Web

2023 ESC Guidelines acute coronary syndromes timing immediate early invasive strategy PCI fibrinolysis

Searching PubMed

"acute coronary syndrome" AND guideline

Reading Web Page

https://www.ahajournals.org/doi/full/10.1161/CIR.00000000000…

Reading Article

PMID: 40014670

Finding Sources

Latest major ACS guidelines

  1. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for Management of Acute Coronary Syndromes
    This is the current major US guideline. It covers unstable angina, NSTEMI, and STEMI in one document, replacing older separate US STEMI/NSTE-ACS guidance. Read the full 2025 ACC/AHA guideline
    Rao et al. (2025), Circulation. PMID: 40014670. Note that PubMed lists a subsequent erratum, PMID: 41212941.
  2. 2023 ESC Guideline for Acute Coronary Syndromes
    This remains the current comprehensive European guideline as of August 2026. View the ESC ACS guideline

Key treatment timelines for suspected ACS

1. First assessment

ActionTarget timeline
Initial assessment, monitoring, IV access, focused history/examinationImmediately
12-lead ECGWithin 10 minutes of first medical contact or ED arrival
Repeat ECG if symptoms continue or initial ECG nondiagnosticSerially, without delay
High-sensitivity troponinAt presentation, then use a validated 0/1-hour or 0/2-hour serial testing pathway where available
Aspirin and antithrombotic/anti-ischemic therapy when indicatedAs soon as ACS is suspected and contraindications are excluded
Do not wait for troponin results in a patient with diagnostic STEMI before activating reperfusion.

2. STEMI reperfusion timeline

Preferred treatment: primary PCI

For STEMI presenting within 12 hours of symptom onset, primary PCI is the preferred reperfusion strategy if it can be delivered promptly.
Clinical situationTimeline/decision
STEMI diagnosedActivate catheterization laboratory immediately
PCI-capable system availablePerform primary PCI as rapidly as possible
Expected first-medical-contact to device time ≤120 minutesTransfer for primary PCI rather than fibrinolysis
Expected first-medical-contact to device time >120 minutes, symptom onset <12 h, no contraindicationGive fibrinolysis promptly, then transfer to a PCI-capable centre
Fibrinolysis operational targetDoor-to-needle / FMC-to-needle ≤30 minutes
Failed fibrinolysisImmediate rescue PCI
Successful fibrinolysisRoutine angiography with intent to PCI at 2-24 hours
Symptoms 12-24 h with ongoing ischemia, heart failure, shock, or electrical instabilityUrgent angiography/PCI is appropriate
Stable patient >48 h after symptom onset with persistently occluded infarct arteryRoutine late PCI of the occluded artery is generally not recommended
The 2025 US guideline uses the key threshold of 120 minutes from first medical contact to device activation to decide between transfer for PCI versus fibrinolysis. ACC/AHA guideline summary

3. NSTEMI and unstable angina: invasive strategy timelines

Fibrinolysis is not indicated for NSTEMI or unstable angina.
Risk categoryExamplesAngiography timing
Very high riskHemodynamic instability/shock, refractory or recurrent chest pain despite treatment, life-threatening arrhythmia, acute heart failure due to ongoing ischemia, mechanical MI complication, recurrent dynamic ST changesImmediate, ideally <2 hours
High riskConfirmed NSTEMI, significant troponin rise/fall, dynamic ST-T changes, transient ST elevation, GRACE score >140Early invasive approach, generally within 24 hours
Intermediate riskDiabetes, renal dysfunction, reduced EF/heart failure history, prior PCI/CABG, recurrent symptoms but no very-high-risk featuresInvasive assessment during the hospital admission, timing based on clinical course and local pathways
Low risk / uncertain ACSNormal serial ECG/troponin and no high-risk featuresObservation, structured rule-out pathway, and selective noninvasive testing or coronary CT angiography where appropriate
The ESC specifically defines immediate invasive management as <2 hours for very-high-risk NSTE-ACS and supports considering angiography within 24 hours for high-risk patients. ESC guidance summary

Immediate medication priorities

TreatmentTiming/principle
AspirinGive promptly unless active major bleeding or true allergy
P2Y12 inhibitorAdd when indicated as DAPT, individualized by planned PCI/CABG strategy and bleeding risk
AnticoagulationStart according to STEMI/NSTE-ACS pathway and intended invasive strategy
OxygenOnly for hypoxemia, respiratory distress, or shock, not routinely in normoxemic patients
NitratesFor ischemic pain if not hypotensive and no right-ventricular infarction or recent PDE-5 inhibitor use
High-intensity statinStart early in all ACS patients unless contraindicated
Beta-blockerEarly oral use if stable; avoid early use in shock, acute heart failure, marked bradycardia, or AV block
ACE inhibitor/ARBStart during admission when indicated, particularly with reduced EF, anterior MI, diabetes, CKD, or hypertension

Key current guideline points after PCI/ACS

  • DAPT: Aspirin plus an oral P2Y12 inhibitor is the default for at least 12 months after ACS in patients without high bleeding risk.
  • High-intensity statin: Recommended for all ACS patients.
  • Radial access: Preferred for PCI when feasible because it reduces bleeding and vascular complications.
  • Complete revascularization: Recommended/considered in appropriate STEMI and multivessel NSTE-ACS patients, depending on anatomy, clinical stability, and comorbidity.
  • Cardiac rehabilitation: Refer before discharge.
  • Lipid follow-up: Obtain a fasting lipid panel about 4-8 weeks after starting or changing lipid-lowering therapy. ACC guideline highlights

Quick memory sequence

ACS suspected → ECG ≤10 min → STEMI?
  • Yes: primary PCI if FMC-to-device ≤120 min.
    If not and symptom onset <12 h: fibrinolysis ≤30 min if eligible, transfer immediately, angiography 2-24 h, rescue PCI if failed lysis.
  • No STEMI: serial hs-troponin and risk stratification.
    Very high risk: angiography <2 h.
    High risk NSTEMI: angiography within 24 h.
    Lower risk: selective invasive/noninvasive approach.
These are clinical-system targets, not a substitute for local emergency protocols or cardiology consultation.

Create a one-page ACS timeline quick-reference PDF

Reading File
Reading File
Searching the Web

2025 ACC AHA acute coronary syndromes guideline key treatment timeline ECG 10 minutes PCI 120 fibrinolysis 30 minutes

Browsing Directory

~/

Running Command

mkdir -p "/tmp/workspace/acs-timeline-pdf/src" "/tmp/workspace/acs-timeline-pdf/output"

Writing File

~/acs-timeline-pdf/src/create_acs_timeline.py

from reportlab.lib.pagesizes import letter
from reportlab.pdfgen import canvas
from reportlab.lib import colors
from reportlab.pdfbase.pdfmetrics import stringWidth
from reportlab.lib.units import inch
from pypdf import PdfReader

OUT = '/tmp/workspace/acs-timeline-pdf/output/ACS_Timeline_Quick_Reference.pdf'
W, H = letter

NAVY = colors.HexColor('#102A43')
BLUE = colors.HexColor('#2563A8')
PALE_BLUE = colors.HexColor('#EAF3FA')
RED = colors.HexColor('#B42318')
PALE_RED = colors.HexColor('#FDECEC')
GREEN = colors.HexColor('#19734A')
PALE_GREEN = colors.HexColor('#EAF7EF')
AMBER = colors.HexColor('#9A6700')
PALE_AMBER = colors.HexColor('#FFF7E6')
GRAY = colors.HexColor('#52606D')
LINE = colors.HexColor('#CBD5E1')
WHITE = colors.white

c = canvas.Canvas(OUT, pagesize=letter)
c.setTitle('ACS Timeline Quick Reference')
c.setAuthor('Orris')

M = 30

def rect(x,y,w,h,fill,stroke=None, radius=0):
    c.setFillColor(fill)
    c.setStrokeColor(stroke or fill)
    if radius:
        c.roundRect(x,y,w,h,radius,fill=1,stroke=1 if stroke else 0)
    else:
        c.rect(x,y,w,h,fill=1,stroke=1 if stroke else 0)

def txt(x,y,text,size=9,color=NAVY,font='Helvetica', maxw=None, leading=None):
    c.setFillColor(color); c.setFont(font,size)
    if maxw is None:
        c.drawString(x,y,text); return y-size
    words=text.split(); lines=[]; line=''
    for word in words:
        test=(line+' '+word).strip()
        if stringWidth(test,font,size) <= maxw: line=test
        else: lines.append(line); line=word
    if line: lines.append(line)
    ld=leading or size*1.25
    for i,ln in enumerate(lines): c.drawString(x,y-i*ld,ln)
    return y-len(lines)*ld

def bold(x,y,text,size=9,color=NAVY):
    return txt(x,y,text,size,color,'Helvetica-Bold')

def pill(x,y,label,bg,fg):
    width=stringWidth(label,'Helvetica-Bold',7.2)+12
    rect(x,y,width,16,bg,radius=8)
    c.setFillColor(fg); c.setFont('Helvetica-Bold',7.2); c.drawCentredString(x+width/2,y+4.5,label)
    return width

def bullet(x,y,text,width,size=8.2,color=NAVY):
    c.setFillColor(BLUE); c.circle(x+3,y+2.6,1.6,fill=1,stroke=0)
    return txt(x+10,y,text,size,color,'Helvetica',width-10,10.2)

# header
rect(0,H-88,W,88,NAVY)
c.setFillColor(WHITE); c.setFont('Helvetica-Bold',22); c.drawString(M,H-43,'ACUTE CORONARY SYNDROME')
c.setFont('Helvetica-Bold',11); c.setFillColor(colors.HexColor('#B9E3FF')); c.drawString(M,H-62,'TIMELINE QUICK REFERENCE  |  Adult suspected ACS')
c.setFont('Helvetica',7.5); c.setFillColor(colors.HexColor('#D9E2EC')); c.drawRightString(W-M,H-62,'2025 ACC/AHA and 2023 ESC guidance')

# immediate action bar
Y=H-112
rect(M,Y-36,W-2*M,36,PALE_BLUE,LINE,5)
bold(M+12,Y-14,'0-10 MIN',10,BLUE)
txt(M+82,Y-14,'Monitor, obtain IV access, focused assessment, and acquire/interpret a 12-lead ECG.',9,NAVY)
txt(M+82,Y-27,'Give aspirin promptly when appropriate. Do not delay STEMI reperfusion for troponin.',8,GRAY)

# diagnostic strip
Y-=56
bold(M,Y,'1. CLASSIFY THE PRESENTATION',11,NAVY)
rect(M,Y-67,174,54,PALE_RED,LINE,5); pill(M+10,Y-31,'STEMI / equivalent',PALE_RED,RED)
txt(M+10,Y-47,'Persistent ST elevation or ischemic',8,NAVY,154)
txt(M+10,Y-58,'equivalent: activate reperfusion.',8,NAVY,154)
rect(M+187,Y-67,174,54,PALE_AMBER,LINE,5); pill(M+197,Y-31,'NSTE-ACS',PALE_AMBER,AMBER)
txt(M+197,Y-47,'No persistent ST elevation:',8,NAVY,154)
txt(M+197,Y-58,'serial hs-troponin + risk stratify.',8,NAVY,154)
rect(M+374,Y-67,174,54,PALE_GREEN,LINE,5); pill(M+384,Y-31,'ONGOING SUPPORT',PALE_GREEN,GREEN)
txt(M+384,Y-47,'Oxygen only if hypoxemia, distress,',8,NAVY,154)
txt(M+384,Y-58,'or shock. Treat instability at once.',8,NAVY,154)

# STEMI Panel
Y-=91
rect(M,Y-229,267,216,colors.HexColor('#FAFCFE'),LINE,6)
rect(M,Y-41,267,28,RED,RED,6)
c.setFillColor(WHITE); c.setFont('Helvetica-Bold',12); c.drawString(M+12,Y-31,'2. STEMI: REPERFUSION PATHWAY')
y=Y-59
bold(M+13,y,'Symptom onset <12 h',9,RED); y-=17
y=bullet(M+13,y,'Primary PCI is preferred when first-medical-contact to device time is 120 min or less.',240); y-=5
y=bullet(M+13,y,'If expected PCI delay is >120 min and no contraindication: give fibrinolysis promptly, then transfer immediately to a PCI centre.',240); y-=5
rect(M+13,y-31,239,29,PALE_RED,None,4)
bold(M+22,y-13,'Fibrinolysis target: needle ≤30 min',8.8,RED)
txt(M+22,y-24,'from hospital arrival / first contact pathway.',7.7,GRAY)
y-=48
y=bullet(M+13,y,'Suspected failed fibrinolysis: immediate rescue PCI.',240); y-=5
y=bullet(M+13,y,'Successful fibrinolysis: angiography with planned PCI at 2-24 h.',240); y-=5
y=bullet(M+13,y,'Ongoing ischemia, shock, acute HF, or electrical instability: urgent angiography/PCI regardless of delay.',240)

# NSTEMI panel
rect(M+282,Y-229,300,216,colors.HexColor('#FAFCFE'),LINE,6)
rect(M+282,Y-41,300,28,AMBER,AMBER,6)
c.setFillColor(WHITE); c.setFont('Helvetica-Bold',12); c.drawString(M+294,Y-31,'3. NSTE-ACS: TIMING OF ANGIOGRAPHY')
y=Y-60
# rows
rows=[
 ('IMMEDIATE  <2 h', 'Very high risk: shock/hemodynamic instability, refractory pain, life-threatening arrhythmia, acute HF, mechanical complication, recurrent dynamic ST changes.', PALE_RED, RED),
 ('EARLY  <24 h', 'High risk: confirmed NSTEMI, dynamic ST-T changes, transient ST elevation, or GRACE >140.', PALE_AMBER, AMBER),
 ('IN-HOSPITAL / SELECTIVE', 'Intermediate risk: invasive assessment during admission. Low-risk or uncertain ACS: selective testing/observation pathway.', PALE_GREEN, GREEN),
]
for label,body,bg,fg in rows:
    rect(M+294,y-49,276,44,bg,None,4)
    bold(M+303,y-18,label,8.4,fg)
    txt(M+303,y-30,body,7.5,NAVY,255,9)
    y-=54
bold(M+294,Y-222,'Do NOT use fibrinolysis for NSTEMI or unstable angina.',8.2,RED)

# medication and disposition
Y-=251
bold(M,Y,'4. EARLY MEDICAL THERAPY AND DISCHARGE CHECKPOINTS',11,NAVY)
rect(M,Y-82,552,68,PALE_BLUE,LINE,5)
# 3 columns
bold(M+12,Y-32,'NOW',8.8,BLUE)
txt(M+12,Y-45,'Aspirin, P2Y12 inhibitor and anticoagulation as indicated. Nitrates if suitable. High-intensity statin early.',7.7,NAVY,164,9.5)
bold(M+194,Y-32,'BEFORE DISCHARGE',8.8,BLUE)
txt(M+194,Y-45,'DAPT plan, secondary prevention, cardiac rehabilitation, smoking cessation, and follow-up.',7.7,NAVY,164,9.5)
bold(M+376,Y-32,'4-8 WEEKS',8.8,BLUE)
txt(M+376,Y-45,'Check fasting lipid panel after starting or changing lipid-lowering therapy.',7.7,NAVY,164,9.5)

# footer caution + sources
Y=42
rect(M,Y,552,30,colors.HexColor('#FFF5F5'),colors.HexColor('#F8B4B4'),5)
bold(M+10,Y+17,'SAFETY:',8.2,RED)
txt(M+58,Y+17,'Use local protocols and senior cardiology/emergency input. This is an educational quick-reference, not a standalone order set.',7.4,NAVY)
txt(M,Y-12,'Sources: 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline (Circulation, PMID 40014670); 2023 ESC ACS Guideline.',6.8,GRAY)
txt(M,Y-22,'Key targets: ECG ≤10 min; PCI decision threshold FMC-to-device 120 min; fibrinolysis target ≤30 min; NSTE-ACS immediate <2 h / early <24 h.',6.8,GRAY)

c.showPage(); c.save()
# Verify one page and extract text
reader=PdfReader(OUT)
assert len(reader.pages)==1, f'Expected one page, got {len(reader.pages)}'
text=reader.pages[0].extract_text()
assert 'ACUTE CORONARY SYNDROME' in text and 'STEMI' in text and 'NSTE-ACS' in text
print(f'Created {OUT} | pages={len(reader.pages)} | text_chars={len(text)}')
Running Command

python "/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py" && ls -lh "/tmp/workspace/acs-timeline-pdf/output/ACS_Timeline_Quick_Reference.pdf"

Reading File
Editing File

~/acs-timeline-pdf/src/create_acs_timeline.py

Successfully replaced 1 instance(s) of the string in '/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py'
Running Command

python "/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py" && ls -lh "/tmp/workspace/acs-timeline-pdf/output/ACS_Timeline_Quick_Reference.pdf"

Reading File
Editing File

~/acs-timeline-pdf/src/create_acs_timeline.py

Successfully replaced 1 instance(s) of the string in '/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py'
Running Command

python "/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py" && ls -lh "/tmp/workspace/acs-timeline-pdf/output/ACS_Timeline_Quick_Reference.pdf"

Editing File

~/acs-timeline-pdf/src/create_acs_timeline.py

Successfully replaced 1 instance(s) of the string in '/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py'
Running Command

python "/tmp/workspace/acs-timeline-pdf/src/create_acs_timeline.py" && ls -lh "/tmp/workspace/acs-timeline-pdf/output/ACS_Timeline_Quick_Reference.pdf"

Created and verified a one-page ACS quick-reference PDF covering ECG, STEMI reperfusion, NSTE-ACS angiography timing, early therapies, and follow-up targets.

ACS Timeline Quick Reference

PDF Document · PDF

This is a shared conversation. Sign in to Orris to start your own chat.